Tom C Hu
Overview
Explore the profile of Tom C Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Satyamitra M, Andres D, Bergmann J, Hoffman C, Hogdahl T, Homer M, et al.
Disaster Med Public Health Prep
. 2023 Oct;
17:e552.
PMID: 37852927
Purpose: To summarize presentations and discussions from the 2022 trans-agency workshop titled "Overlapping science in radiation and sulfur mustard (SM) exposures of skin and lung: Consideration of models, mechanisms, organ...
2.
Pantazides B, Crow B, Quinones-Gonzalez J, Perez J, Harvilchuck J, Wallery J, et al.
Anal Bioanal Chem
. 2021 Jan;
413(6):1765-1776.
PMID: 33511457
Chlorine is a toxic industrial chemical with a history of use as a chemical weapon. Chlorine is also produced, stored, and transported in bulk making it a high-priority pulmonary threat...
3.
Wu R, Zhai Y, Kuick R, Karnezis A, Garcia P, Naseem A, et al.
J Pathol
. 2016 Aug;
240(3):341-351.
PMID: 27538791
Endometrioid carcinoma (EC) is a relatively indolent ovarian carcinoma subtype that is nonetheless deadly if detected late. Existing genetically engineered mouse models (GEMMs) of the disease, based on transformation of...
4.
Wu R, Baker S, Hu T, Norman K, Fearon E, Cho K
Am J Pathol
. 2013 Mar;
182(4):1391-9.
PMID: 23499052
A dualistic pathway model of ovarian carcinoma (OvCA) pathogenesis has been proposed: type I OvCAs are low grade, genetically stable, and relatively more indolent than type II OvCAs, most of...
5.
Wu R, Hu T, Rehemtulla A, Fearon E, Cho K
Clin Cancer Res
. 2011 Sep;
17(23):7359-72.
PMID: 21903772
Purpose: Genetically engineered mouse (GEM) models of ovarian cancer that closely recapitulate their human tumor counterparts may be invaluable tools for preclinical testing of novel therapeutics. We studied murine ovarian...